Minoxidil vs Glow Blend
Side-by-side comparison of Minoxidil and Glow Blend: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Minoxidil
Glow Blend
Minoxidil
Minoxidil is an FDA-approved treatment for pattern hair loss. Originally an oral blood-pressure drug, its hair-growth side effect led to the topical products (Rogaine) at 2% and 5%. It is a potassium-channel-opening…
Lowest listed price: $29.99 across 1 listing
Full Minoxidil profileGlow Blend
GHK-Cu + BPC-157 + TB-500 blend for skin and recovery
Lowest listed price: $99.99 across 3 listings
Full Glow Blend profileSide-by-side comparison
| Attribute | Minoxidil | Glow Blend |
|---|---|---|
| Category | Skin & Hair | Recovery |
| Research Stage | FDA-Approved | Preclinical |
| Mechanism of Action | Minoxidil is a small-molecule vasodilator first developed as an oral antihypertensive. Its hair-growth effect was discovered as a side effect (hypertrichosis) and later formulated into topical products. Minoxidil is a PRODRUG. It must be converted to its… | Glow Blend is a fixed combination of three research peptides, so its proposed effects are simply the sum of what each component does on its own - there is no unique "blend" mechanism, and no pharmacology study has ever been run on the three together. Each part… |
| Half-Life | Oral minoxidil plasma half-life is approximately 3-4 hours; the hair-growth (pharmacodynamic) effect is independent of plasma level and depends on ongoing daily use. | Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend. |
| Typical Dose Range | Oral low-dose minoxidil (off-label): 625-5000 mcg/day (0.625-5 mg). Topical minoxidil is dosed by concentration (2% or 5%), not by mcg -- roughly 10-20 mg of minoxidil is delivered per topical application, with only ~1.4% absorbed systemically. | Blend - stated per component: GHK-Cu 1000-2000 mcg/day; BPC-157 250-500 mcg/dose; TB-500 2000-2500 mcg/dose. No validated dose exists for the combination (Research Use Only). |
| Dosing Frequency | Topical: once daily (5% foam) to twice daily (2%/5% solution). Oral low-dose minoxidil (off-label): once daily. | GHK-Cu once daily; BPC-157 once to twice daily; TB-500 twice weekly during the loading phase, then every 1-2 weeks for maintenance. |
| Administration | — | — |
| Side Effects | Topical (most common, usually mild): - Scalp irritation, itching, dryness, flaking/dandruff -- more with the propylene-glycol solution than the foam [PMID:21700360]. - Temporary increased shedding in the first 2-8 weeks. - Unwanted facial or body hair… | Most reported effects are local: injection-site redness, swelling, itching, bruising or transient pain, plus mild skin sensitivity. GHK-Cu injections can sting, and with prolonged high-dose systemic use there is a theoretical concern for copper accumulation.… |
| Molecular Weight | 209.24 g/mol (C9H15N5O) | — |
| Common Vial Sizes | — | — |
Price tracking
Price tracking
Minoxidil: potential benefits
- Regrows hair and slows further loss in androgenetic alopecia / female pattern hair loss -- its best-supported use, backed by multiple randomized placebo-controlled trials [PMID:12196747][PMID:15034503].
- In men, 5% topical produced roughly 45% more non-vellus hair regrowth than 2% at 48 weeks, with an earlier response [PMID:12196747].
- Increases hair count and hair-shaft width and improves scalp coverage and the psychosocial impact of hair loss [PMID:15034503].
- Once-daily 5% foam is non-inferior to twice-daily 2% solution in women and causes less scalp irritation and dandruff [PMID:21700360].
- Low-dose oral minoxidil (off-label) is a convenient option for people who dislike or cannot tolerate topical, with efficacy comparable to topical 5% in men [PMID:38598226][PMID:32622136].
- Used off-label as an adjunct in other hair disorders such as telogen effluvium, traction alopecia, chemotherapy-induced alopecia, and scarring alopecias [PMID:32622136].
Glow Blend: potential benefits
- Improved skin firmness and elasticity - GHK-Cu raised collagen and elastin and improved aged-skin firmness in controlled cosmetic studies [PMID:18644225]
- Reduced appearance of fine lines and photodamage (GHK-Cu cosmetic data) [PMID:18644225]
- Support for wound and connective-tissue repair - GHK-Cu and BPC-157 accelerated healing in animal models [PMID:8836453][PMID:30915550]
- Angiogenesis / improved local blood-vessel formation - a shared mechanism of BPC-157 and the thymosin beta-4 fragment in TB-500 [PMID:20388964][PMID:14500546]
- Faster recovery from tendon, ligament and muscle strain (BPC-157 preclinical data) [PMID:30915550]
- Anti-inflammatory and antioxidant support during recovery (GHK-Cu and thymosin beta-4) [PMID:18644225][PMID:27450738]
- Reported skin 'glow' and quicker soft-tissue recovery - community/anecdotal only, not clinically verified for the blend
Frequently asked
What's the difference between Minoxidil and Glow Blend?
Minoxidil is a skin & hair that minoxidil is a small-molecule vasodilator first developed as an oral antihypertensive. its hair-growth effect was discovered as a side effect (hypertrichosis) and later formulated…. Glow Blend is a recovery that glow blend is a fixed combination of three research peptides, so its proposed effects are simply the sum of what each component does on its own - there is no unique "blend"…. The two differ in mechanism, half-life (Oral minoxidil plasma half-life is approximately 3-4 hours; the hair-growth (pharmacodynamic) effect is independent of plasma level and depends on ongoing daily use. vs Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend.), and typical dose range.
Which has the longer half-life, Minoxidil or Glow Blend?
Minoxidil has a half-life of Oral minoxidil plasma half-life is approximately 3-4 hours; the hair-growth (pharmacodynamic) effect is independent of plasma level and depends on ongoing daily use.. Glow Blend has a half-life of Varies by component - the blend has no single half-life. BPC-157 and the TB-500 (thymosin beta-4) fragment are small peptides cleared over hours; GHK-Cu is a short-lived tripeptide-copper complex. Community dosing frequency is driven by empirical practice, not by measured pharmacokinetics of the blend.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, Minoxidil or Glow Blend?
Lowest listed price on BodyHackGuide: Minoxidil from $29.99, Glow Blend from $99.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack Minoxidil and Glow Blend?
Stacking depends on mechanism overlap, safety profile, and goals. Minoxidil and Glow Blend should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Minoxidil or Glow Blend
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.